Skip to content
healthcare.dev

GAMMAGARD Liquid ERC

NDC 0944-2705, Immune Globulin Infusion (Human), injection, solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
0944-2705
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125105
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2705 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN IMMUNOGLOBULIN G100 mg/mL

Pharmacologic classes

Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
0944-2705-10009442705101 VIAL, GLASS in 1 CARTON (0944-2705-10) / 100 mL in 1 VIAL, GLASS (0944-2705-01)
0944-2705-50009442705501 VIAL, GLASS in 1 CARTON (0944-2705-50) / 50 mL in 1 VIAL, GLASS (0944-2705-05)

Linked data

RxNorm, label and prices

Use it

Look up 0944-2705 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2705 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0944-2705. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.